Keywords: Actelion, 2009 financial results, Tracleer, R&D pipeline
Soaring Tracleer sales boost Actelion’s 2009 financial results
Article | 19 February 2010
Switzerland-based Actelion, Europe’s largest biotechnology company, pleased investors yesterday after posting full-year 2009 results and offering a bullish outlook for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
